跳至主要内容
临床试验/CTRI/2025/07/090580
CTRI/2025/07/090580尚未招募4 期

Evaluation of Anxiolytic and Analgesic effect of Intranasal spray of Dexmedetomidine in patients undergoing surgical removal of impacted mandibular third molar: A Randomised Clinical Trial

Rupinder Kaur1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2025年8月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
42
试验地点
1
主要终点
reduction in anxiety and stress levels

研究概览

简要总结

The study aims to assess anxiety levels before and after administration of intranasal spray of Dexmedetomidine which is a mild sedative and is effective for relaxation stress management and post operative analgesia as well.

Dexmedetomidine is a centrally acting selective alfa 2 adrenoreceptor agonist and is a tasteless and odourless drug.

研究设计

研究类型
Interventional

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • •Patients willing to give informed consent Patients who are anxious ASA class I patients Patients who on evaluation have moderate surgical difficulty score on Pederson index.

排除标准

  • •Patients not willing to participate Patients with systemic illness Patients already on longterm sedatives or analgesic use Patients with acute rhinitis upper respiratory tract infection cvs diseases and allergy to dexmedetomidine Pregnant or lactating females.

结局指标

主要结局

reduction in anxiety and stress levels

时间窗: 30 minutes

次要结局

  • reduction in anxiety and stress levels(30 minutes)

研究者

发起方
Rupinder Kaur
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Rupinder Kaur

KAHER KLE VKIDS Belagavi

研究点 (1)

Loading locations...

相似试验